Figure 5.
Figure 5. C1 inhibitor and HRG regulate the plasminogen activator function of αFXIIa. The impact of inhibitors on αFXIIa-polyP70 plasminogen activator function was monitored in the absence (black) or the presence (gray) of PAI-1 (1 nM), PAI-2 (1 nM), C1 inhibitor (500 nM), or HRG (1 μM) by absorbance-based clot lysis (A) or by plasminogen activation assay in which plasmin was detected by cleavage of S2251 (B). For simplicity, the controls in the absence of polyP70 are not shown, because no lysis was observed in either the absence or presence of the inhibitor. Data represent mean ± SEM (n = 3).

C1 inhibitor and HRG regulate the plasminogen activator function of αFXIIa. The impact of inhibitors on αFXIIa-polyP70 plasminogen activator function was monitored in the absence (black) or the presence (gray) of PAI-1 (1 nM), PAI-2 (1 nM), C1 inhibitor (500 nM), or HRG (1 μM) by absorbance-based clot lysis (A) or by plasminogen activation assay in which plasmin was detected by cleavage of S2251 (B). For simplicity, the controls in the absence of polyP70 are not shown, because no lysis was observed in either the absence or presence of the inhibitor. Data represent mean ± SEM (n = 3).

Close Modal

or Create an Account

Close Modal
Close Modal